Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-10-01 · accession 0001477449-24-000219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-02 | 2024-10-01 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | — | +2,631 | 29.1K | +10% | — |
| D | 2024-10-02 | 2024-10-02 | TDOC | Bliss Kelly | Pres, U.S. Group Health | S - Sale+OE | $8.68 | -897 | 28.2K | -3% | -$7,786 |
| D | 2024-10-02 | 2024-10-01 | TDOC | Bliss Kelly | Pres, U.S. Group Health | M - OptEx | $0.00 | -2,631 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | M | A | 2,631 | — | 29,100 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| 2 | Common | Common Stock | 2024-10-02 | S | D | 897 | $8.68 | 28,203 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 3 | Derivative | Restricted Stock Units | 2024-10-01 | M | D | 2,631 | $0.00 | 0 | D | — · — to — | 2,631 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. |